Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Wegovy
This Wegovy tag gathers 3 current articles on price moves, investor impacts, and Medicare/Ozempic coverage, helping you understand how drug costs affect budgets and retirement planning.
4 articles
Will Medicare Cover Ozempic? What Retirees Should Know About GLP-1 Coverage
GLP-1 drugs like Ozempic and Wegovy are changing the cost landscape for retirees. This guide breaks down what Medicar...
Novo Nordisk Cuts Wegovy Prices, Stock Near 52-Week Low
Novo Nordisk signals a major Wegovy price cut set for January 2027, triggering a sharp market reaction as the stock s...
Novo Nordisk Stock Investors Adjust to Eli Lilly News
Novo Nordisk stock investors faced volatility after softer results and cautious guidance, but momentum around Wegovy ...